Obeticholic Acid for Prevention in Barrett's Esophagus

Clinical trial NCT04939051 · RECRUITING

Trial details

NCT number: NCT04939051
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Barrett Esophagus Esophageal Adenocarcinoma

Start date: 2024-01-03
Primary completion: 2027-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.